| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 24.834 | 20.142 | 42.434 | 74.936 | 87.545 | 95.360 | 104.590 | 113.139 | 150.025 | 171.938 |
| Total Income - EUR | 31.359 | 20.142 | 42.598 | 76.639 | 87.541 | 116.640 | 104.591 | 113.139 | 150.207 | 171.940 |
| Total Expenses - EUR | 37.616 | 20.064 | 36.888 | 51.422 | 60.971 | 65.189 | 51.367 | 59.698 | 66.167 | 77.049 |
| Gross Profit/Loss - EUR | -6.258 | 78 | 5.709 | 25.217 | 26.570 | 51.451 | 53.224 | 53.442 | 84.041 | 94.891 |
| Net Profit/Loss - EUR | -7.199 | -324 | 4.259 | 24.451 | 25.829 | 50.349 | 52.178 | 52.311 | 82.569 | 89.836 |
| Employees | 1 | 1 | 2 | 2 | 3 | 2 | 2 | 3 | 3 | 3 |
Check the financial reports for the company - Lyl Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 518 | 405 | 29.012 | 23.996 | 17.994 | 48.234 | 36.873 | 69.052 | 51.310 | 34.743 |
| Current Assets | 23.080 | 2.075 | 8.955 | 27.832 | 10.722 | 15.405 | 27.828 | 67.454 | 34.182 | 60.583 |
| Inventories | 16 | 14 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 612 | 896 | 3.241 | 4.449 | 5.701 | 5.788 | 6.431 | 5.889 | 19.049 | 807 |
| Cash | 22.452 | 1.164 | 5.714 | 23.382 | 5.022 | 9.617 | 21.397 | 61.565 | 15.133 | 59.776 |
| Shareholders Funds | 19.207 | -280 | 3.984 | 24.494 | 6.486 | 50.391 | 58.893 | 49 | 82.617 | 89.884 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.392 | 2.760 | 33.983 | 27.334 | 22.230 | 13.248 | 5.808 | 136.457 | 2.875 | 5.442 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Lyl Med Srl